Camden Capital, LLC Amgen Inc Transaction History

Camden Capital, LLC

  • $1.25 Billion
  • Q2 2024

A detailed history of Camden Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Camden Capital, LLC holds 2,249 shares of AMGN stock, worth $719,072. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,249
Previous 1,302 72.73%
Holding current value
$719,072
Previous $370,000 89.73%
% of portfolio
0.06%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$262.75 - $319.31 $248,824 - $302,386
947 Added 72.73%
2,249 $702,000
Q1 2024

May 15, 2024
SELL
$268.87 - $324.56 $287,690 - $347,279
-1,070 Reduced 45.11%
1,302 $370,000
Q4 2023

Feb 05, 2024
BUY
$255.7 - $288.46 $200,980 - $226,729
786 Added 49.56%
2,372 $683,000
Q3 2023

Nov 03, 2023
SELL
$218.65 - $271.46 $3,498 - $4,343
-16 Reduced 1.0%
1,586 $426,000
Q2 2023

Aug 09, 2023
BUY
$214.27 - $253.37 $32,569 - $38,512
152 Added 10.48%
1,602 $355,000
Q1 2023

May 11, 2023
BUY
$225.79 - $275.2 $28,901 - $35,225
128 Added 9.68%
1,450 $350,000
Q4 2022

Feb 13, 2023
SELL
$229.03 - $291.01 $63,441 - $80,609
-277 Reduced 17.32%
1,322 $347,000
Q3 2022

Nov 08, 2022
SELL
$224.46 - $253.15 $83,274 - $93,918
-371 Reduced 18.83%
1,599 $360,000
Q2 2022

Aug 03, 2022
BUY
$230.71 - $256.74 $20,533 - $22,849
89 Added 4.73%
1,970 $480,000
Q1 2022

May 06, 2022
BUY
$219.27 - $242.57 $30,039 - $33,232
137 Added 7.86%
1,881 $455,000
Q4 2021

Feb 28, 2022
SELL
$198.88 - $227.6 $212,801 - $243,532
-1,070 Reduced 38.02%
1,744 $392,000
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $5,966 - $6,828
-30 Reduced 1.05%
2,814 $633,000
Q3 2021

Nov 03, 2021
BUY
$212.27 - $248.7 $256,209 - $300,180
1,207 Added 73.73%
2,844 $605,000
Q2 2021

Aug 16, 2021
BUY
$233.58 - $259.14 $47,183 - $52,346
202 Added 14.08%
1,637 $399,000
Q1 2021

May 10, 2021
BUY
$221.91 - $258.6 $46,823 - $54,564
211 Added 17.24%
1,435 $357,000
Q4 2020

Feb 04, 2021
BUY
$216.38 - $257.67 $30,509 - $36,331
141 Added 13.02%
1,224 $281,000
Q3 2020

Oct 30, 2020
BUY
$234.65 - $260.95 $41,063 - $45,666
175 Added 19.27%
1,083 $275,000
Q2 2020

Aug 11, 2020
BUY
$197.81 - $242.74 $179,611 - $220,407
908 New
908 $214,000
Q1 2020

Apr 13, 2020
SELL
$182.24 - $241.7 $182,604 - $242,183
-1,002 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$189.21 - $243.2 $189,588 - $243,686
1,002 New
1,002 $242,000

Others Institutions Holding AMGN

# of Institutions
3,055
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email